Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvorexant vs Zolpidem in Healthy Volunteers
NCT04273776Phase 1Active, not recruiting
- Sponsor
- Walter Reed Army Institute of Research
- Start
- Dec 2019
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Insomnia comparing Suvorexant Arm, Zolpidem Arm and Placebo Arm (3 arms). Primary endpoints: Consolidation of episodic memory at 5 days and Psychomotor vigilance test at 4 days. Started Dec 2019; status: active, not recruiting.
02
Drugs
suvorexantzolpidem
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT04273776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04273776.